Literature DB >> 32352362

Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China.

Yu Liu1, Christopher Chang2,3, Qianjin Lu1.   

Abstract

Entities:  

Year:  2020        PMID: 32352362      PMCID: PMC7431340          DOI: 10.5152/eurjrheum.2020.2056

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


× No keyword cloud information.
  28 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  COVID-19 in posttransplant patients-report of 2 cases.

Authors:  Jiaofeng Huang; Heng Lin; Yinlian Wu; Yingying Fang; Rahul Kumar; Gongping Chen; Su Lin
Journal:  Am J Transplant       Date:  2020-04-17       Impact factor: 8.086

3.  [Recommendations for normalizing the medical practices of burn treatment during the outbreak of coronavirus disease 2019].

Authors:  S Y Ma; Z Q Yuan; Y Z Peng; Q Z Luo; H P Song; F Xiang; J L Tan; J Y Zhou; N Li; G Z Hu; G X Luo
Journal:  Zhonghua Shao Shang Za Zhi       Date:  2020-06-20

4.  COVID-19: the new challenge for rheumatologists.

Authors:  Francesco Ferro; Elena Elefante; Chiara Baldini; Elena Bartoloni; Ilaria Puxeddu; Rosaria Talarico; Marta Mosca; Stefano Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2020-03-24       Impact factor: 4.473

Review 5.  The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.

Authors:  Pranab Chatterjee; Nazia Nagi; Anup Agarwal; Bhabatosh Das; Sayantan Banerjee; Swarup Sarkar; Nivedita Gupta; Raman R Gangakhedkar
Journal:  Indian J Med Res       Date:  2020 Feb & Mar       Impact factor: 2.375

6.  What is the role of rheumatologists in the era of COVID-19?

Authors:  Daniela Marotto; Piercarlo Sarzi-Puttini
Journal:  Autoimmun Rev       Date:  2020-04-03       Impact factor: 9.754

7.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

8.  Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.

Authors:  Chi Zhang; Zhao Wu; Jia-Wen Li; Hong Zhao; Gui-Qiang Wang
Journal:  Int J Antimicrob Agents       Date:  2020-03-29       Impact factor: 5.283

9.  Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.

Authors:  Tracy H T Lai; Emily W H Tang; Sandy K Y Chau; Kitty S C Fung; Kenneth K W Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.535

10.  Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Authors:  Awadhesh Kumar Singh; Akriti Singh; Altamash Shaikh; Ritu Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-26
View more
  4 in total

Review 1.  What Has Changed in the Treatment of Psoriatic Arthritis After COVID-19?

Authors:  Yaşar Keskin; Gökhan Koz; Kemal Nas
Journal:  Eurasian J Med       Date:  2021-06

Review 2.  The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.

Authors:  Aristo Vojdani; Elroy Vojdani; Avi Z Rosenberg; Yehuda Shoenfeld
Journal:  Pathophysiology       Date:  2022-06-03

3.  Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy.

Authors:  Pamela Vezzoli; Marco Di Mercurio; Andrea Carugno; Daniele Mario Gambini; Elisa Robustelli Test; Gianlorenzo Imberti; Angelo Francesco Castagna; Paolo Sena
Journal:  Dermatol Ther       Date:  2020-07-03       Impact factor: 3.858

4.  Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.

Authors:  Zaure Mukusheva; Maikesh Assylbekova; Dimitri Poddighe
Journal:  Rheumatol Int       Date:  2020-06-08       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.